logo

NSCR

Nuveen Sustainable Core ETF·NASDAQ
--
--(--)
--
--(--)
Nuveen Sustainable Core ETF Fundamentals
Assets Under Management
6.34MUSD
Fund Flows (1Y)
267.80KUSD
Dividend Yield (TTM)
2.07%
Discount/Premium to NAV
0.02%
Shares Outstanding
220.00K
Expense Ratio
0.45%
Returns
1-Month
3-Month
YTD
1-Year
3-Year
5-Year
Price Performance
-5.41%-8.78%-7.40%+6.19%+14.13%+14.13%
NAV Total Return
-6.19%-8.74%-7.36%+8.35%+0.11%+0.11%
Ratings

Aime Ratings

No data is currently available

No data is currently available

Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis

Sector

Technology

29.95%

Consumer Cyclical

11.98%

Industrials

11.78%

Healthcare

11.18%

Financial Services

9.88%

Communication Services

9.42%

Energy

5.78%

Utilities

3.85%

Consumer Defensive

3.84%

Show more

Asset

Region

100%

Category

Ratio

North America

100.00%

Top 10 Holdings

Symbol

Ratio

logo

AAPL

Apple
7.87%
logo

MSFT

Microsoft
5.35%
logo

NVDA

Nvidia
4.61%
logo

AVGO

Broadcom
3.97%
logo

AMZN

Amazon.com
3.74%
logo

JNJ

Johnson & Johnson
3.62%
logo

GOOGL

Alphabet A
3.44%
logo

META

Meta
3.16%
logo

GOOG

Alphabet C
2.73%
logo

MA

Mastercard
2.54%

Top 10 Weight 41.03%

60 Total Holdings

Is SPY better than NSCR?
Dividends

Dividend Payout History

Ex-Div Date
Record Date
Payment Date
Amount
2025-12-182025-12-182025-12-190.251
2024-12-182024-12-182024-12-190.232
How Much Does NSCR Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy NSCR?
Fund Flows